Computational Modeling for Controlled Release Microparticle Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing controlled release therapeutics require extensive and costly in vitro testing to achieve a suitable drug release profile, as the formulation process has not significantly evolved since the inception of controlled release technology, and there is a lack of understanding on which properties, such as polymer degradation mechanism or matrix crystallinity, primarily influence the release pattern.
Innovation Solution
A method is developed to create a modified release composition by selecting an active agent and polymer matrix, assessing degradation effects, predicting performance based on molecular weights, and determining optimal ratios to achieve a specified release profile, resulting in sustained release microparticles with defined molecular weights and weight percentages, which can sustain drug release for extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional iterative in vitro testing methods are used to develop controlled release formulations, then a suitable drug release profile can be achieved, but the development process becomes time-consuming and costly
Solution Approach 1:
The patent applies preliminary action by using computational models to predict drug release profiles before physical formulation is created. The model calculates release characteristics based on polymer properties, particle size, and drug characteristics, allowing formulation scientists to screen multiple formulations in silico before selecting candidates for in vitro testing, thereby reducing development time and costs
Solution Approach 2:
The patent creates a virtual copy of the drug delivery system through computational modeling. The model replicates the complex interactions between polymer degradation, drug diffusion, and erosion processes, enabling virtual testing and optimization of release profiles without requiring physical prototypes, thus accelerating the development process
2Manufacturing precision
If traditional iterative in vitro testing methods are used to develop controlled release formulations, then a suitable drug release profile can be achieved, but the development cost increases
Solution Approach 1:
The computational model performs preliminary screening of formulation parameters, allowing scientists to identify promising formulations before investing in expensive in vitro testing resources. By predicting release profiles computationally, the number of physical experiments required is reduced, thereby lowering development costs
Solution Approach 2:
The virtual modeling approach creates digital replicas of formulation performance, eliminating the need for repeated physical prototyping and testing cycles. This digital copying reduces consumption of materials, equipment usage, and laboratory resources, directly reducing development costs
3Ease of manufacture
If simple polymer matrices are used, then formulation is easier, but the release profile control is limited
Solution Approach 1:
The patent employs parameter changes by systematically varying polymer molecular weight, particle size, drug loading, and polymer composition ratios within the computational model. This allows exploration of how different parameters affect release profiles, enabling customization of release characteristics while maintaining relatively simple formulation approaches
Solution Approach 2:
The model handles composite polymer systems, such as blends of different polymers or core-shell structures, allowing complex release profiles to be achieved through material composition rather than complex formulation processes. The computational approach makes it feasible to evaluate composite material options that would be difficult to optimize through trial-and-error manufacturing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach eliminates the need for exploratory in vitro experiments, allowing for the prediction and design of controlled release formulations that produce a broad array of custom release profiles, reducing development time and costs while ensuring effective and sustained drug delivery.
Implementation Method 1
assessing degradation effect on release of the active agent from the composition
Data Source
AI summary
A method for making a modified release composition, comprising:selecting a desired active agent and polymer matrix for formulating into a modified release composition;assessing degradation effect on release of the active agent from the composition including plotting polymer molecular weight (Mwr) at onset of active agent release vs. active agent molecular weight (MwA);predicting performance of multiple potential formulations for the composition based on the degradation assessment and average polymer matrix initial molecular weight (Mwo) to define a library of building blocks;determining the optimal ratio of the building blocks to satisfy a specified release profile; andmaking a modified release composition based on the optimal ratio determination.